Understanding complex disease requires new approaches to interrogating the underlying biology. The Spatial Genomics Summit will showcase novel techniques that provide spatial context to high-plex molecular profiling. Attendees of the summit will hear four presentations describing spatial genomics techniques and applications, followed by a panel discussion on the state of this emerging field and what the future looks like for this research.
“We believe that spatial context is the next frontier in biological research,” said
The Spatial Genomics Summit will be held on
- Delivering on the promise of Spatial Genomics,
Joseph Beechem, PhD, NanoString Technologies
- Tools for in situ molecular interrogation spanning the resolution and throughput spectrum,
Fei Chen, PhD, The Broad Institute
- Mapping the brain with multiplexed error robust fluorescence in situ hybridization,
Jeffrey Moffitt, PhD, Boston Children's Hospital
- Spatial Transcriptomics for monitoring ALS disease dynamics,
Sanja Vickovic, PhD, The Broad Institute
- Integrating bulk and spatial profiling technologies for the discovery of RNA and protein biomarkers in muscle invasive bladder cancer,
Victoria Rimkunas, PhD, H3 Biomedicine
To register for the Summit, please visit https://www.nanostring.com/company/events-archive/spatial-genomics-summit.
GeoMx DSP enables high plex spatial profiling of RNA and protein targets. Using photocleavable indexes, tens to thousands of targets can be spatially profiled without destroying precious tissue samples. Over the last two years, the GeoMx DSP Technology Access Program (TAP) has enabled users to send samples to
To learn more about GeoMx DSP, please visit https://www.nanostring.com/scientific-content/technology-overview/digital-spatial-profiling-technology.
About NanoString Technologies, Inc.
For more information, please visit www.nanostring.com.
Source: NanoString Technologies, Inc.